Tandem Diabetes Care, Inc. (TNDM)
Insulin pump maker, one pattern. Read November 9, 2026 from the annual report for the period ending December 31, 2025, filed February 19, 2026. Ranked 124 of the 145 Healthcare companies read so far, by the share within reach now.
Within reach now
29%
projected from METR's April 2026 measurement and Epoch's November 2026 index
End of 2028
38%
Employees, annual report
2,500
Leading staffing pattern
Medical Equipment and Supplies Manufacturing
Share of the working time within reach, long-run pace, four times in five
Now is projected from METR's April 2026 measurement and Epoch's November 2026 index.
- Now29%
- End of 202736%
- End of 202838%
- End of 203038%
What changes for its people by the end of 2028, by its industries' figures
- Stays with people 57%
- Becomes checking a model's work 36%
- Handed over with lighter checks 6%
The filing states approximately 2,500 regular full-time employees at December 31, 2025, primarily in the United States, Canada or Europe, and describes one insulin pump business, so the whole workforce is read at medical equipment manufacturing by description.
The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.
What follows from the reading
Share of working time within reach of AI, on the long-run pace at four in five: 29% now, 36% at the end of 2027, 38% at the end of 2028, 38% at the end of 2030. By the patterns, the work is about 38% desk work, 16% people work and 46% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 57% of the working time stays with people (conversation, in-person and hands-on work), 36% becomes checking a model's work and 6% could be handed over with lighter checks, from the industries' own figures, not the company's roles.
Headcount
2,500 employees as of December 31, 2025 (stated). Stated in words only: employees primarily work in the United States, Canada or Europe.
The filing: “As of December 31, 2025, we had approximately 2,500 regular full-time employees, who primarily work in the United States, Canada, or Europe.”
The workforce as industry patterns
| Pattern | Share | Reason, from the filing |
|---|---|---|
| Medical Equipment and Supplies Manufacturing | 100% | The filing describes an insulin pump maker with research and development, administration, a manufacturing facility and a warehousing facility at its San Diego headquarters, with no count by function, so the whole workforce is read at medical equipment and supplies manufacturing by description (c). |
What the filing says about the workforce: Approximately 2,500 regular full-time employees at December 31, 2025, primarily in the United States, Canada or Europe, down from 2,650; no collective bargaining agreement; more than 200 employees in leadership development programs in 2025.
Companies read with the same leading pattern
Other companies whose largest staffing pattern is also Medical Equipment and Supplies Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five. Now is projected from METR's April 2026 measurement and Epoch's November 2026 index.
- Abbott Laboratories (ABT, 115,000 employees)28% now, 37% by 2028
- Becton, Dickinson and Company (BDX, 72,000 employees)29% now, 38% by 2028
- Boston Scientific Corporation (BSX, 59,000 employees)32% now, 44% by 2028
- Stryker Corporation (SYK, 56,000 employees)30% now, 41% by 2028
- Baxter International Inc. (BAX, 37,500 employees)30% now, 39% by 2028
- Align Technology, Inc. (ALGN, 20,290 employees)29% now, 38% by 2028
- Solventum Corporation (SOLV, 20,000 employees)33% now, 45% by 2028
- STERIS plc (STE, 17,937 employees)33% now, 41% by 2028
What the filing says about AI
7 sentences in the filing name AI. The filing names AI in its risk factors: its employees may use artificial intelligence technologies including generative AI in their work, the use of personal data in AI is subject to privacy laws, and governments are likely to pass more laws regulating generative AI.
- “Our employees and personnel may use Artificial Intelligence (AI) technologies (including generative AI) to perform their work.”
- “The use and disclosure of personal data in AI technologies is subject to various data privacy laws and other data privacy obligations.”
- “Governments have passed and are likely to pass additional laws regulating generative AI.”
- “If we are unable to use AI, it could make our business less efficient and result in competitive disadvantages.”
- “Our systems, those of the third parties with whom we work, and the underlying data are vulnerable to damage or interruption from a variety of threats, including without limitation earthquakes, fires, floods, other natural disasters, terrorist attacks, social-engineering attacks (including phishing and deep fakes, which may be increasingly more difficult to identify as fake), malicious code (suc...”
Its annual reports, year by year
Sentences naming AI in each annual report, counted by one rule, beside the median report in the Index that year. Each count links its filing. Every company, by year and sector
- Fiscal 20212median 0
- Fiscal 20222median 0
- Fiscal 202320median 1
- Fiscal 20247median 4
- Fiscal 20257median 10
Headcount by filing year
As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.
| Period | Employees | Filed | Filing |
|---|---|---|---|
| 2025-12-31 | 2,500 | 2026-02-19 | 10-K |
| 2024-12-31 | 2,650 | 2025-02-26 | 10-K |
| 2023-12-31 | 2,400 | 2024-02-21 | 10-K |
| 2022-12-31 | 2,600 | 2023-02-22 | 10-K |
| 2021-12-31 | 2,000 | 2022-02-22 | 10-K |
| 2020-12-31 | 1,500 | 2021-02-24 | 10-K |
| 2019-12-31 | 1,043 | 2020-02-24 | 10-K |
| 2018-12-31 | 653 | 2019-02-26 | 10-K |
| 2017-12-31 | 574 | 2018-03-01 | 10-K |
| 2016-12-31 | 591 | 2017-03-08 | 10-K |
| 2015-12-31 | 482 | 2016-02-24 | 10-K |
| 2014-12-31 | 437 | 2015-02-24 | 10-K |
| 2013-12-31 | 324 | 2014-03-06 | 10-K |
Limits of this reading
- The count is of regular full-time employees; no part-time or temporary figure is stated.
- The U.S. share is given in words and left null.
- No count by function; one pattern by description (c).
Source: the company's annual report on EDGAR, accession 0001438133-26-000010, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.
The report on Tandem Diabetes Care, Inc., $29
This page as a document to keep, with what it does not show: the share within reach at every date on three paces and two reliabilities, a typical workforce of this shape at the stated headcount role by role and task by task (the industries' staffing, never the company's roster), where to start, what changes for the people and what they would learn, every sentence in the filing that names AI, the headcount by year, the companies read with the same leading pattern, the method and a citation line. To print or save as a PDF, open again in your browser for a year.
See the report, $29See the sample first: Walmart's report is free
Questions about this company
- How much of Tandem Diabetes Care, Inc.'s working time is within reach of AI?
- An estimated 29% now and 38% by the end of 2028, on METR's long-run pace at four in five, from the workforce Tandem Diabetes Care, Inc.'s own annual report describes and BLS staffing patterns for its industries, never from a roster. It is an estimate with a stated method. It is not a forecast of jobs lost or of savings, and it says nothing about what the company will do.
- How many people does Tandem Diabetes Care, Inc. employ?
- 2,500 as of December 31, 2025, as its annual report for the period ending December 31, 2025 states.
- What kinds of work make up Tandem Diabetes Care, Inc.'s workforce?
- Read from its annual report as a blend of 1 industry staffing pattern, the largest Medical Equipment and Supplies Manufacturing; by those patterns the work is about 38% desk work, 16% people work and 46% body work. Each share has a one-sentence reason on this page that can be checked against the filing.
- What does Tandem Diabetes Care, Inc.'s annual report say about AI?
- 7 sentences in the filing name AI. Its annual reports for fiscal 2021 to 2025 name it in 2, 2, 20, 7 and 7 sentences, year by year. They are counted and quoted on this page, never judged: a count says how much a filing talks about AI, not what the company does with it.
- How is this estimated?
- Claude Fable 5.1 read the annual report under the Index's written rubric (version 1) on November 9, 2026: the stated headcount, the share in the U.S. when stated, and the workforce as a blend of industry staffing patterns. The estimates are the site's industry estimates weighted by those shares, from O*NET tasks with estimated lengths and METR's measurements of how long a task AI models can finish. A company can write to info@stratussc.com to have its reading checked against its filing.
Embed these figures on your site
A small card with the share of working time within reach now and at the end of 2027, 2028 and 2030, the date and a link back. Free under CC BY 4.0; the card carries the credit.